{"id":186689,"name":"CONSUMER HEALTHCARE PRODUCTS ASSOCIATION","slug":"consumer-healthcare-products-association","state":"DC","description":"Manufacturers &amp; distributors of non-prescription OTC medicines and dietary supplements.","totalSpending":1520000,"filings":29,"yearlySpending":[{"year":2018,"income":200000},{"year":2019,"income":100000},{"year":2020,"income":200000},{"year":2021,"income":200000},{"year":2022,"income":200000},{"year":2023,"income":200000},{"year":2024,"income":240000},{"year":2025,"income":180000}],"firms":["KOUNTOUPES DENHAM CARR & REID, LLC"],"lobbyists":["JULIE CARR","LORI DENHAM","ADAM HECHAVARRIA","MARY BEAL","LESLIE ZELENKO"],"issues":["ALC","TAX","HCR","PHA",null],"sampleDescriptions":["Issues related to the sale of medicines that contain dextromethorphan, including H.R. 1271, the DXM Abuse Prevention Act of 2017.","Issues related to the eligibility of over the counter drugs to be purchased using HSA and FSA accounts, including H.R.394 and S.85, both entitled Restoring Access to Medication Act of 2017, and H. R. 4618.","Issues related to the over the counter drug monograph process including H. R. 5333, the Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018 and S. 2315, the Over-the-Counter Drug Safety, Innovation, and Reform Act.","General issues related to over the counter pharmaceuticals.  Issues related to draft legislation addressing the over the counter drug monograph process including H. R. 5333, the Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018 and S. 2315, the Over-the-Counter Drug Safety, Innovation, and Reform  Act.","Issues related to the eligibility of over the counter drugs to be purchased using HSA and FSA accounts, including H.R.394 and S.85, both entitled Restoring Access to Medication Act of 2017, H. R. 4618, and H. R. 6199.","Issues related to the sale of medicines that contain dextromethorphan, including H. R. 863, the DXM Abuse Prevention Act of 2019.","Issues related to the over the counter drug monograph process including H.R.269, the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 and H. R. 3443, the Over-the-counter Monograph Safety, Innovation, and Reform Act of 2019. Issues related to sunscreen.","Issues related to the eligibility of over the counter drugs to be purchased using HSA and FSA accounts, including H.R. 1922.","General issues related to over the counter pharmaceuticals.  Issues related to draft legislation addressing the over the counter drug monograph process including H.R.269, the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 and H. R. 3443, the Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019.","General issues related to over the counter pharmaceuticals.  Issues related to draft legislation addressing the over the counter drug monograph process including H.R.269 and H. R. 3443, the Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019.","Issues related to the over the counter drug monograph process including H. R. 3443/S.2740, the Over-the-counter Monograph Safety, Innovation, and Reform Act of 2019. Issues related to sunscreen. H.R. 748, Coronavirus Aid, Relief, and Economic Security Act.","General issues related to over the counter pharmaceuticals.  Issues related to draft legislation addressing the over the counter drug monograph process including H. R. 3443/S2740, the Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019. H.R. 748, Coronavirus Aid, Relief, and Economic Security Act.","Issues related to the eligibility of over the counter drugs and feminine hygiene products to be purchased using HSA and FSA accounts, including H.R. 1922.  H.R. 748, Coronavirus Aid, Relief, and Economic Security Act.","H.R. 1922/S.1089 Restoring Access to Medication Act, legislation to include certain over the counter medications as qualified medical expenses.  Issues related to HSA/FSA coverage of dietary supplements, and H.R. 748 Coronavirus Aid, Relief and Economic Security Act (Cares Act).  Issues related to supplements.","Issues related to the over the counter drug monograph process including H. R. 3443/S.2740, the Over-the-counter Monograph Safety, Innovation, and Reform Act of 2019. Issues related to sunscreen. H.R. 748, Coronavirus Aid, Relief, and Economic Security Act.  H.R. 5279, Cosmetic Safety Enhancement Act.","General issues related to over the counter pharmaceuticals and pharmaceutical supply chain.  H.R. 3443/S.2740, the Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019. H.R. 748, Coronavirus Aid, Relief, and Economic Security Act.","Implementation of the Over the Counter Monograph and sunscreen provisions included in PL 116-136, Coronavirus Aid, Relief and Economic Security Act.  H.R. 5279, Cosmetic Safety Enhancement Act.","General issues related to over the counter pharmaceuticals and pharmaceutical supply chain.  Implementation of the Over the Counter Monograph provisions included in PL 116-136, Coronavirus Aid, Relief and Economic Security Act.  Issues related to supplements.","Implementation of the Restoring Access to Medications Act included in PL 116-136 the Coronavirus Aid, Relief and Economic Security Act.  Issues related to supplements.  Issues related to the implementation and collection of User Fees for over the counter medicines regulated by monograph including the FY21 continuing resolution.","Implementation of the Over the Counter Monograph and sunscreen provisions included in Pl 116-136, Coronavirus, Aid, Relief and Economic Security Act.  Issues related to the expansion of FSAs and HSAs for dietary supplements.  Issues related to cosmetic safety."],"years":[2018,2019,2020,2021,2022,2023,2024,2025]}